The orthobiologics market is estimated to be valued at US$ 6,515.2 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Orthobiologics products are used to aid in the regeneration of injured or damaged bones and tissues. They include bone grafts, bone graft substitutes, stem cells, cell-based matrices, and growth factors & cytokines. ... Read more
